Deciphera Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Deciphera Pharmaceuticals has a total shareholder equity of $350.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $473.6M and $122.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$306.22m |
| Equity | US$350.92m |
| Total liabilities | US$122.65m |
| Total assets | US$473.57m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: D05's short term assets ($381.1M) exceed its short term liabilities ($100.3M).
Long Term Liabilities: D05's short term assets ($381.1M) exceed its long term liabilities ($22.4M).
Debt to Equity History and Analysis
Debt Level: D05 is debt free.
Reducing Debt: D05 has no debt compared to 5 years ago when its debt to equity ratio was 0.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: D05 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: D05 has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 12.8% each year.